SVP

Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors

Retrieved on: 
Tuesday, April 2, 2024

Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages of pre-clinical development

Key Points: 
  • Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages of pre-clinical development
    PARIS, FRANCE; SAN FRANCISCO, U.S., 02 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY) and Sutro Biopharma (NASDAQ: STRO, “Sutro”, “the Company”) today announced an exclusive global licensing agreement for STRO-003.
  • “The potential for ADCs in oncology is well-documented and we are excited by the addition of STRO-003, Ipsen’s first ADC candidate with best-in-class potential.” said Mary Jane Hinrichs, SVP and Head of Early Development at Ipsen.
  • “STRO-003 is a next-generation ROR1 ADC, leveraging Sutro’s site-specific technology to generate a highly stable conjugate, coupled with exatecan payloads, that have shown significant potential in solid tumors.
  • Payloads are the pharmaceutically active component to treat the cancer, attached to the antibody via a chemical linker.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME

Retrieved on: 
Monday, April 1, 2024

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME).

Key Points: 
  • NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME).
  • 7980
    The investigation concerns whether Zymeworks and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer

Retrieved on: 
Monday, April 1, 2024

“I am pleased to welcome Jonas to Gain and look forward to his contributions.

Key Points: 
  • “I am pleased to welcome Jonas to Gain and look forward to his contributions.
  • His academic work focused on immuno-neurology, particularly on the effect of systemic inflammation on myeloid cells in the brain.
  • Previously, he served as Chief Medical Officer at Tranquis Therapeutics and Capacity Bio, SVP of Clinical Development at Alkahest, Medical Director at Denali Therapeutics, and Director of Neuroscience Discovery Medicine at UCB Pharma.
  • “Looking at the extensive data package that the Gain team has generated during preclinical development, Gain’s lead drug candidate GT-02287 has a first and best-in-class profile.

Tim Haynes Appointed as RealManage's Chief Executive Officer

Retrieved on: 
Friday, March 29, 2024

Plano, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- RealManage, one of the nation’s leading community association management companies, is excited to announce the appointment of Tim Haynes as its new Chief Executive Officer.

Key Points: 
  • Plano, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- RealManage, one of the nation’s leading community association management companies, is excited to announce the appointment of Tim Haynes as its new Chief Executive Officer.
  • Mr. Haynes brings a wealth of experience in operations, client service, and technology to his new role as CEO.
  • He joined RealManage last February as the Chief Operating Officer and has since focused his attention on leading RealManage’s operations nationwide and delivering industry-leading service for over 3,000 community association clients.
  • Tim has proven himself to be an exceptional leader, and we all believe that this is the right time to make this transition."

Tangram and Co/Action Partner on Program for Franchised Equipment Dealers

Retrieved on: 
Thursday, March 28, 2024

PETALUMA, Calif. and MORRISTOWN, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tangram Insurance Services, Inc. (Tangram) and Co/Action Specialty Insurance Group (Co/Action) are pleased to announce a partnership which will provide a comprehensive insurance program for franchised equipment dealers (FEDs).

Key Points: 
  • PETALUMA, Calif. and MORRISTOWN, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tangram Insurance Services, Inc. (Tangram) and Co/Action Specialty Insurance Group (Co/Action) are pleased to announce a partnership which will provide a comprehensive insurance program for franchised equipment dealers (FEDs).
  • “The addition of this nationwide, exclusive program for FEDs is a clear demonstration of Tangram’s and Co/Action’s continued commitment to providing valuable insurance and risk management programs to specialty niche markets,” said Tracy Bernard, SVP of Program Strategy at Tangram.
  • This new program will be available nationwide, except in AK, HI and LA, and is offered exclusively through Tangram.
  • “Tangram is a trusted partner and is emblematic of the kind of differentiated relationship we seek at Co/Action.

Meltwater partners with leading digital agency Social Factor

Retrieved on: 
Thursday, March 28, 2024

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Meltwater, a leading global provider of media, social and consumer intelligence, today announces a new partnership with Social Factor, a global digital agency focusing on social CRM and strategy.

Key Points: 
  • SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Meltwater, a leading global provider of media, social and consumer intelligence, today announces a new partnership with Social Factor, a global digital agency focusing on social CRM and strategy.
  • With this partnership, Meltwater and Social Factor customers will be able to leverage the best of Meltwater’s social analytics and social media management solutions alongside Social Factor’s specialization in social media operations and community management.
  • Social Factor helps enterprise-level clients turn digital chaos into human connection through content moderation, community management, analytical data, governance, training, and security.
  • At Social Factor, we believe in the power of authentic connections and community building,” said Scott Parker, CEO of Social Factor.

Stallion Uranium Strengthens Board with Technical Expertise

Retrieved on: 
Thursday, March 28, 2024

“We are privileged to have the technical expertise and experience of Matthew Schwab joining Stallion’s Board of Directors.

Key Points: 
  • “We are privileged to have the technical expertise and experience of Matthew Schwab joining Stallion’s Board of Directors.
  • As Stallion continues to advance exploration across its land package, Mr. Schwab’s experience will further bolster the strength of Stallion’s team as we work to make the next significant uranium discovery,” commented Drew Zimmerman, CEO of Stallion Uranium.
  • Mr. Schwab is currently the CEO of Kraken Energy Corp, a US focused uranium exploration and development company.
  • “I’m honoured by the opportunity to join the Board of Directors at Stallion and believe my technical background will further bolster a strong team as we work toward a significant uranium discovery.”
    The company would like to thank Terry Wells for his commitment and service to the Stallion Board and Audit Committee over the past few years.

Zoomcar Partners with ACKO Drive; Empowers Local Hosts to Increase Car Fleet on its Car-Sharing Marketplace Platform

Retrieved on: 
Wednesday, March 27, 2024

BENGALURU, India, March 27, 2024 (GLOBE NEWSWIRE) -- Zoomcar Holdings, Inc. (“Zoomcar” or the “Company”) (Nasdaq: ZCAR), the NASDAQ-listed leading marketplace for self-drive car sharing, has partnered with ACKO Drive, a car buying platform by ACKO, to empower local Zoomcar Hosts to expand their car fleet.

Key Points: 
  • BENGALURU, India, March 27, 2024 (GLOBE NEWSWIRE) -- Zoomcar Holdings, Inc. (“Zoomcar” or the “Company”) (Nasdaq: ZCAR), the NASDAQ-listed leading marketplace for self-drive car sharing, has partnered with ACKO Drive, a car buying platform by ACKO, to empower local Zoomcar Hosts to expand their car fleet.
  • With this partnership, ACKO Drive is offering Zoomcar Hosts substantial savings of up to INR 85,000 on new car purchases along with attractive offers on car financing with instant loan approval, express car delivery and more.
  • Zoomcar Hosts earned approximately $4 million according to Zoomcar’s Q3 2023 results , and are focused on making car hosting just as popular as car renting.
  • Through this collaboration, ACKO Drive will facilitate easier access to Zoomcar Hosts by extending exclusive offers, which will further enable them to increase their earnings potential from car sharing.

LifeLabs Unveils At Home Kit Program, Empowering Ontarians to Prioritize Health with Ease

Retrieved on: 
Tuesday, March 26, 2024

LifeLabs’ At Home Kit Program provides a diverse range of self-collection kits for various health tests, including cervical to colorectal health, hormonal health, and blood sugar monitoring.

Key Points: 
  • LifeLabs’ At Home Kit Program provides a diverse range of self-collection kits for various health tests, including cervical to colorectal health, hormonal health, and blood sugar monitoring.
  • This proactive and private solution caters to individuals with busy schedules, those facing accessibility challenges, and anyone prioritizing their wellness journey.
  • “Our mission at LifeLabs is to empower individuals to achieve optimal health by facilitating access to essential medical testing and supporting healthy lifestyle habits,” said Charles Brown, President and CEO of LifeLabs.
  • “The Cervical Health (HPV) Kit provides remarkable convenience for those who prioritize regular testing.

Flywire survey: Luxury travelers planning to spend more on vacations and take longer trips compared to last year

Retrieved on: 
Tuesday, March 26, 2024

BOSTON, March 26, 2024 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW), a global payments enablement and software company, has released its third annual report on luxury travelers' preferences, finding 90% of their vacations will be longer than ones they took a few years ago. 87% of the same group also plan to spend more on travel in 2024 than they did last year; this number jumps to 95% when looking specifically at Gen Z and Millennials.

Key Points: 
  • Flywire’s annual luxury travel report surveyed approximately 675 luxury travelers in the U.S. to understand how their preferences and plans could impact the travel industry in 2024.
  • The report explores topics around AI in travel, sustainability, hybrid work’s influence on luxury vacations, payment security and more.
  • Overall, these trends are positive indicators for travel providers who cater to the luxury market.”
    Even in the age of AI, luxury travelers prefer working with people.
  • In most instances, they still want to use a travel agent or advisor to help plan their trips.